Biodegradable Stents - Global Market Outlook (2016-2022)

  • ID: 4426180
  • Report
  • Region: Global
  • 160 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Limited
  • Biotronik
  • BIOTRONIK SE & Co. KG
  • Meril Life Sciences
  • MORE
The Global Biodegradable Stents market accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in treatment of artery disease is rapidly providing market growth. Patients demand for minimal invasive surgeries, growing geriatric population and technological advancements are some of the factors driving market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.

Hospitals segment is expected to dominate the market, it is because of majority hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate application segment on account of growing geriatric population and rising consequences of disease occurring. In geographical segment, North America is estimated to dominate the market due to high prevalence of cardiovascular diseases. In addition to that, Asia Pacific market is expected to grow at highest CAGR attributing to growing awareness about Bioabsorbable stents.

Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies), Tepha, Inc. and Xenogenics Corporation.

End-Users Covered:
  • Cardiac Centers
  • Hospitals
Applications Covered:
  • Coronary Artery Disease
  • Peripheral Artery Disease
Materials Covered:
  • Metallic Stents
  • Polymeric Stents
Drugs covered:
  • Limus-Based Drugs
  • Paclitaxel
Absorption Rates covered:
  • Slow-Absorption Stents
  • Fasto Absorption Stents
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of APAC
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Limited
  • Biotronik
  • BIOTRONIK SE & Co. KG
  • Meril Life Sciences
  • MORE
1. Executive Summary

2. Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3. Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End-User Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4. Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5. Global Biodegradable Stents Market, By End-User
5.1 Introduction
5.2 Cardiac Centers
5.3 Hospitals

6. Global Biodegradable Stents Market, By Application
6.1 Introduction
6.2 Coronary Artery Disease
6.3 Peripheral Artery Disease

7. Global Biodegradable Stents Market, By Material
7.1 Introduction
7.2 Metallic Stents
7.3 Polymeric Stents

8. Global Biodegradable Stents Market, By Drug
8.1 Introduction
8.2 Limus-Based Drugs
8.3 Paclitaxel

9. Global Biodegradable Stents Market, By Absorption Rate
9.1 Introduction
9.2 Slow-Absorption Stents
9.3 Fast-Absorption Stents

10. Global Biodegradable Stents Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11. Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12. Company Profiling
12.1 Abbott Laboratories
12.2 Amaranth Medical, Inc.
12.3 Arterial Remodeling Technologies SA
12.4 Arterius Limited
12.5 BIOTRONIK SE & Co. KG
12.6 Biotronik
12.7 Elixir Medical Corporation
12.8 Kyoto Medical Planning Co., Ltd.
12.9 Meril Life Sciences
12.10 REVA Medical, Inc.
12.11 SMT (Part of Sahajanand Group of Companies)
12.12 Tepha, Inc.
12.13 Xenogenics Corporation

List of Tables

Table 1 Global Biodegradable Stents Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
Table 3 Global Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
Table 4 Global Biodegradable Stents Market Outlook, By Hospitals (2014-2022) ($MN)
Table 5 Global Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
Table 6 Global Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
Table 7 Global Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
Table 8 Global Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
Table 9 Global Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
Table 10 Global Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
Table 11 Global Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
Table 12 Global Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
Table 13 Global Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
Table 14 Global Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
Table 15 Global Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
Table 16 Global Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
Table 17 North America Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
Table 18 North America Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
Table 19 North America Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
Table 20 North America Biodegradable Stents Market Outlook, By Hospitals (2014-2022) ($MN)
Table 21 North America Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
Table 22 North America Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
Table 23 North America Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
Table 24 North America Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
Table 25 North America Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
Table 26 North America Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
Table 27 North America Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
Table 28 North America Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
Table 29 North America Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
Table 30 North America Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
Table 31 North America Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
Table 32 North America Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
Table 33 Europe Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
Table 34 Europe Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
Table 35 Europe Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
Table 36 Europe Biodegradable Stents Market Outlook, By Hospitals (2014-2022) ($MN)
Table 37 Europe Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
Table 38 Europe Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
Table 39 Europe Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
Table 40 Europe Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
Table 41 Europe Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
Table 42 Europe Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
Table 43 Europe Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
Table 44 Europe Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
Table 45 Europe Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
Table 46 Europe Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
Table 47 Europe Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
Table 48 Europe Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
Table 49 Asia Pacific Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
Table 50 Asia Pacific Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
Table 51 Asia Pacific Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
Table 52 Asia Pacific Biodegradable Stents Market Outlook, By Hospitals (2014-2022) ($MN)
Table 53 Asia Pacific Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
Table 54 Asia Pacific Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
Table 55 Asia Pacific Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
Table 56 Asia Pacific Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
Table 57 Asia Pacific Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
Table 58 Asia Pacific Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
Table 59 Asia Pacific Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
Table 60 Asia Pacific Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
Table 61 Asia Pacific Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
Table 62 Asia Pacific Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
Table 63 Asia Pacific Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
Table 64 Asia Pacific Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
Table 65 RoW Biodegradable Stents Market Outlook, By Country (2014-2022) ($MN)
Table 66 RoW Biodegradable Stents Market Outlook, By End-User (2014-2022) ($MN)
Table 67 RoW Biodegradable Stents Market Outlook, By Cardiac Centers (2014-2022) ($MN)
Table 68 RoW Biodegradable Stents Market Outlook, By Hospitals (2014-2022) ($MN)
Table 69 RoW Biodegradable Stents Market Outlook, By Application (2014-2022) ($MN)
Table 70 RoW Biodegradable Stents Market Outlook, By Coronary Artery Disease (2014-2022) ($MN)
Table 71 RoW Biodegradable Stents Market Outlook, By Peripheral Artery Disease (2014-2022) ($MN)
Table 72 RoW Biodegradable Stents Market Outlook, By Material (2014-2022) ($MN)
Table 73 RoW Biodegradable Stents Market Outlook, By Metallic Stents (2014-2022) ($MN)
Table 74 RoW Biodegradable Stents Market Outlook, By Polymeric Stents (2014-2022) ($MN)
Table 75 RoW Biodegradable Stents Market Outlook, By Drug (2014-2022) ($MN)
Table 76 RoW Biodegradable Stents Market Outlook, By Limus-Based Drugs (2014-2022) ($MN)
Table 77 RoW Biodegradable Stents Market Outlook, By Paclitaxel (2014-2022) ($MN)
Table 78 RoW Biodegradable Stents Market Outlook, By Absorption Rate (2014-2022) ($MN)
Table 79 RoW Biodegradable Stents Market Outlook, By Slow-Absorption Stents (2014-2022) ($MN)
Table 80 RoW Biodegradable Stents Market Outlook, By Fast-Absorption Stents (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA
  • Arterius Limited
  • BIOTRONIK SE & Co. KG
  • Biotronik
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Meril Life Sciences
  • REVA Medical, I
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll